Image: Jim Kopp
Intranasal stem cell therapy may one day treat brain disorders
Many diseases of the central nervous system involve the death of neurons—so, theoretically, the replacement of dead cells should improve symptoms of degenerative disorders such as Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and Alzheimer’s, as well as stroke and brain tumors. Stem cell therapy may do just that even though evidence of its effectiveness is mixed.
In any cell transplant procedure, the host organ—in this case, the brain—may reject its new additions. Further, it is unclear whether grafted cells can truly integrate into complex neural circuitry. Finally, current procedures require invasive surgical implantation, which can be expensive and risky. The surgery can cause neural inflammation, and the implanted cells may quickly die.
Intranasal administration may address at least some of these issues. Most important, it eliminates the need for surgery. Further, some research suggests that stem cells delivered intranasally are “smart”—they do not spread through the brain indiscriminately but instead target damaged cells.
The Latest on: Intranasal stem cell therapy
[google_news title=”” keyword=”Intranasal stem cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Intranasal stem cell therapy
- Stem cell transplant success rate in blood cancer treatment is around 80%: Expertson May 26, 2023 at 4:53 am
Over one lakh new blood cancer cases are reported every year. Effective treatment methods, awareness around the disease and prevalence of myths are among the chief reasons why this disease continues ...
- Global Stem Cell Research Leader CHA Medical & Bio Group Expands Global Presence with Launch of Anti-Aging Research Institute in L.A.on May 25, 2023 at 12:38 pm
LOS ANGELES — Medical & Bio Group, a global leader in stem cell research based in South Korea, announced its plan to establish the CHA Power Aging Research Translational Institute in Los Angeles. The ...
- Six nanotechnology companies to watch out foron May 25, 2023 at 8:38 am
As techniques and tools to exploit nanotechnology in the field of healthcare progresses, here are six nanotechnology companies that are widening the scope in medicine, that you should know about.
- Tiziana Life Sciences To Host KOL Webinar On Foralumab In Non-Active Secondary Progressive Multiple Sclerosis (SPMS)on May 25, 2023 at 4:39 am
Tiziana Life Sciences Ltd. (Nasdaq: tlsa ) (“Tiziana” or the“Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced it ...
- Scientists target human stomach cells for diabetes therapyon May 24, 2023 at 5:00 pm
Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a ...
- Decoding stem cells for personalised regenerative medicineon May 24, 2023 at 5:21 am
Researchers developed a personalised stem cell therapy using data-driven, single-cell technique based on swift subcellular proteomic imaging.
- Can Stem Cells Be Used as Treatment for Osteoporosis?on May 23, 2023 at 3:16 am
One potential new treatment for osteoporosis is the use of stem cells. But research into stem cells for osteoporosis is still in its early stages. Learn more about osteoporosis. The cells of our ...
- Scientists call for regulation of stem cell 'treatment' fadson May 22, 2023 at 1:33 pm
The findings have been published in the journal Stem Cell Research & Therapy. Dr. Darius Widera, an Associate Professor at the University of Reading and lead author of the research, said ...
- Tonix Pharmaceuticals Announces Clinical Proof-Of-Concept Study Of TNX-1900 (Intranasal Potentiated Oxytocin)on May 22, 2023 at 4:24 am
Intranasal Oxytocin Blocks the Release of CGRP in Animal Models Intranasal Oxytocin is the Core Technology of TNX-1900 for Migraine
- Stem cell therapy reduces symptoms of progressive MS for some peopleon May 19, 2023 at 9:01 pm
An experimental stem cell therapy may reduce some symptoms of progressive multiple sclerosis, primarily in people with severe disability from the disease. Multiple sclerosis (MS) is a chronic ...
via Bing News
